- cafead Aug 09, 2024 at 11:52: AM
via US-based Pulse Biosciences has treated the first two patients with atrial fibrillation (AF) in the first-in-human feasibility study using its novel cardiac surgery system.
The two patients were treated at St Antonius Hospital in the Netherlands, initiating the first-in-human feasibility study. The patients tolerated the procedure well, said Pulse’s chief medical officer of cardiac surgery Gan Dunnington.
article source
The two patients were treated at St Antonius Hospital in the Netherlands, initiating the first-in-human feasibility study. The patients tolerated the procedure well, said Pulse’s chief medical officer of cardiac surgery Gan Dunnington.
article source